C84.61 Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck

Name of the Condition

• Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck (ICD-10 Code: C84.61)

Summary

Anaplastic large cell lymphoma, ALK-positive, lymph nodes of head, face, and neck (ALCL, ALK-positive) is a rare subtype of non-Hodgkin lymphoma that primarily affects T-lymphocytes. It is characterized by the presence of the anaplastic lymphoma kinase (ALK) protein, resulting from a specific genetic rearrangement. This condition typically presents as a rapidly growing tumor involving the lymph nodes of the head, face, and neck. ALCL, ALK-positive is more common in children and young adults and is generally considered aggressive but responsive to targeted therapies.

Causes

The exact cause of ALK-positive ALCL is not fully understood. The disease is driven by a genetic translocation involving the ALK gene, most commonly the t(2;5)(p23;q35) translocation, which results in overexpression of the ALK protein. This abnormal protein promotes uncontrolled cell growth and survival. While the translocation is a key driver, other genetic mutations may contribute to disease development, though specific environmental triggers remain unclear.

Risk Factors

• Age: More common in children and young adults, with a peak incidence in the second and third decades of life.
• Gender: Slightly higher prevalence in males.
• Genetic factors: Presence of the ALK translocation is a primary risk factor.
• Immunosuppression: Weakened immune systems may increase risk.

Symptoms

• Swollen lymph nodes in the head, face, or neck.
• Rapidly growing masses or tumors in affected areas.
• Fever, night sweats, or unexplained weight loss (B symptoms).
• Fatigue, loss of appetite, or general malaise.
• Skin lesions or rashes (if the disease spreads beyond lymph nodes).

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI scans), and biopsy of the affected lymph nodes. Pathologists examine tissue samples for the presence of ALK protein using immunohistochemistry or molecular testing. Additional tests, such as flow cytometry or genetic analysis, may confirm the diagnosis and rule out other lymphomas.

Treatment Options

Treatment typically includes systemic therapies such as chemotherapy, targeted therapy (e.g., ALK inhibitors), or immunotherapy. Radiation therapy may be used for localized disease. The choice of treatment depends on the stage of the disease, patient age, and overall health. Clinical trials may be an option for some patients.

Prognosis and Follow-Up

Prognosis varies based on factors like disease stage, response to treatment, and patient age. ALK-positive ALCL generally has a better prognosis than ALK-negative subtypes, especially in younger patients. Follow-up care includes regular monitoring for recurrence, imaging studies, and blood tests. Long-term survivors may require ongoing surveillance for late effects of treatment.

Complications

• Disease progression or recurrence.
• Treatment-related side effects (e.g., infection risk, organ toxicity).
• Metastasis to other organs or tissues.
• Secondary malignancies from chemotherapy or radiation.

Lifestyle & Prevention

• Maintain a healthy immune system through balanced nutrition and regular exercise.
• Avoid known carcinogens (e.g., tobacco, excessive alcohol).
• Practice good hygiene to reduce infection risk.
• Follow recommended cancer screening guidelines for early detection.

When to Seek Professional Help

Seek medical attention if you experience persistent swollen lymph nodes, unexplained weight loss, fever, or other symptoms of lymphoma. Early diagnosis and treatment improve outcomes. Consult a hematologist or oncologist for specialized care.

Tips for Medical Coders

When coding for C84.61, ensure the documentation specifies involvement of lymph nodes in the head, face, or neck. Verify that the ALK-positive status is confirmed, as this distinguishes it from other lymphoma subtypes. Document the site clearly to support accurate code assignment. Review clinical notes for details on biopsy results, genetic testing, or treatment plans to ensure comprehensive coding.